Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 156,944	$ 199,252
Restricted cash	526	525
Short-term investments	148,788	121,407
Accounts receivable, net	112,642	133,563
Inventory	224,000	258,616
Prepaid and other current assets	7,316	11,618
Total current assets	650,216	724,981
Property, plant and equipment, net	24	114
Long-term inventory	74,023	77,615
Operating lease right-of-use asset	7,984	8,310
Other long-term assets	1,250	1,360
Intangible asset, net	17,118	19,304
TOTAL ASSETS	750,615	831,684
Current Liabilities:
Accounts payable	40,507	52,762
Accrued expenses and other current liabilities	161,047	204,174
Current deferred revenue		2,341
Total current liabilities	201,554	259,277
Long-Term Liabilities:
Long-term deferred revenue		2,509
Long-term operating lease liability	8,215	8,737
Other long-term liabilities	9,471	9,064
Total liabilities	219,240	279,587
Commitments and contingencies (Note 5)
Stockholders’ Equity:
Common stock, GBP 0.50 par, unlimited authorized; 421,994,431 shares issued, 411,261,678 shares outstanding as of September 30,2024; 418,141,295 shares issued, 408,824,093 shares outstanding as of December 31, 2023	305,202	302,756
Additional paid-in capital	1,911,445	1,899,456
Treasury stock; 10,732,753 shares as of September 30, 2024; 9,317,202 shares as of December 31, 2023	(65,344)	(63,752)
Accumulated deficit	(1,619,928)	(1,586,363)
Total stockholders’ equity	531,375	552,097
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 750,615	$ 831,684